-
-
-
-
-
-
-
Valion Bio (Nasdaq:VBIO): Oral Mucosal Entolimod Could Offer a New Needle-Free Deployment Path to Support Growing Need for Scalable Civilian Radiation Preparedness Should Nuclear Infrastructure Expand
-
-
-
-
-
-
-
Valion Bio names CFO Lisa Wolf as president and COO after CEO exits
-
-
-
-
-
-
-
Sheba Medical Center to trial Valion Bio's Entolimod in cancer patients
-
-
-
-
-
-
481,518 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


